the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Australian PM supports removing Prince Andrew from succession line

Prime Minister Anthony Albanese backs calls to remove Prince Andrew from the royal line of succession following his arrest, urging a full investigation.

SYDNEY: Australian Prime Minister Anthony Albanese has formally backed calls to remove former prince Andrew from the royal line of succession.

In a letter to his UK counterpart Keir Starmer, Albanese stated that his government would agree to any proposal to remove Andrew from the succession.

“These are grave allegations and Australians take them seriously,” Albanese added in his correspondence.

The British government is now considering passing a law to remove Andrew Mountbatten-Windsor from the line of succession following his detention last week on suspicion of misconduct in public office.

King Charles III had already stripped his younger brother of all royal titles and ousted him from his Windsor home amid revelations from the files of late US sex offender Jeffrey Epstein.

Despite this, the son of the late Queen Elizabeth II remains eighth in line to the British throne, following Princess Lilibet, the daughter of his nephew Prince Harry.

Charles issued a rare, personally signed statement insisting that “the law must take its course” while attempting to maintain business as usual.

Albanese, who personally favours changing Australia to a republic, told Starmer he agreed with the king’s position.

“The law must now take its full course and there must be a full, fair and proper investigation,” the prime minister wrote.

Australia, a former British colony for over a century which gained de facto independence in 1901, has never become a fully fledged republic.

In a 1999 referendum, Australians narrowly voted against removing Queen Elizabeth II as their head of state.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings